acyclovir vs tenofovir disoproxil

How to Read This acyclovir vs tenofovir disoproxil Comparison

acyclovir is classified in the Antiviral (Nucleoside Analog) drug class, while tenofovir disoproxil sits within the Nucleotide Reverse Transcriptase Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acyclovir has 31,277 submissions while tenofovir disoproxil has 42,720. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these two drugs are both filtered out of the body by the kidneys, which can increase the risk of kidney strain when used at the same time.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acyclovir and tenofovir disoproxil — always consult your physician or pharmacist first.